Gabapentin does not typically increase eye pressure, and in some clinical settings it has actually been shown to reduce temporary spikes in eye pressure. However, one notable study found a statistical link between gabapentin use and a specific type of glaucoma called acute angle-closure, which involves a sudden rise in eye pressure. The picture is more nuanced than a simple yes or no.
How Gabapentin Affects Eye Pressure
In controlled settings, gabapentin appears to lower eye pressure rather than raise it. Researchers studying patients undergoing general anesthesia found that gabapentin blunted the spike in eye pressure that normally happens when a breathing tube is placed. The proposed explanation: gabapentin may relax the ciliary muscle inside the eye by blocking certain calcium channels, which improves the drainage of fluid through the eye’s natural outflow pathway. This is actually similar to how some blood pressure medications reduce eye pressure as a secondary effect.
Gabapentin has also been shown to increase tear production through a separate mechanism involving water-channel proteins in the tear glands and cornea. This effect is relevant to dry eye rather than pressure, but it illustrates that gabapentin interacts with eye tissues in multiple ways.
The Link to Acute Angle-Closure Glaucoma
Despite the pressure-lowering observations above, a large nested case-control study using insurance claims data found that people who took gabapentin in the year before diagnosis had a 42% higher relative risk of developing acute angle-closure glaucoma compared to non-users. That result was statistically significant. When researchers looked only at people currently taking gabapentin at the time of diagnosis, the association weakened and was no longer statistically significant (28% higher risk, but with a wide confidence interval).
Acute angle-closure glaucoma is different from the more common open-angle type. It happens when the drainage angle inside the eye suddenly narrows or closes, trapping fluid and causing a rapid pressure spike. Symptoms come on fast: severe eye pain, headache, nausea, blurred vision, and seeing halos around lights. It’s a medical emergency.
Researchers at the American Academy of Ophthalmology theorized that gabapentin may trigger this in susceptible people through a mechanism similar to topiramate, another seizure medication. Topiramate can cause the ciliary body (the structure that produces eye fluid) to swell and shift forward, physically pushing the iris toward the drainage angle and blocking it. Gabapentin may do something similar, though the evidence is far less established. For comparison, a Bayesian meta-analysis found topiramate carries nearly four times the odds of acute angle-closure glaucoma. Gabapentin’s association is much weaker, and there wasn’t enough published data on gabapentin to include it in that same meta-analysis.
Who Is Most at Risk
Acute angle-closure glaucoma is far more likely in people who already have narrow drainage angles in their eyes. You may be at higher risk if you are farsighted, female, over 60, or of East Asian descent, as these groups tend to have anatomically narrower angles. If you’ve been told during an eye exam that your angles are narrow or “occludable,” that information is especially relevant when starting any medication linked to angle-closure risk.
People with open-angle glaucoma, the most common form, face a different situation. No specific contraindication for gabapentin exists in this population. The FDA prescribing information for gabapentin (brand name Neurontin) lists “glaucoma” only as a rare adverse event observed across all clinical trials, without specifying the type or providing a frequency percentage.
Vision Side Effects Listed on the Label
The FDA-approved label for gabapentin lists several eye-related side effects from controlled trials. Blurred vision occurred in about 2.7% of patients taking gabapentin for nerve pain after shingles, compared to 0.9% on placebo. Double vision was reported by roughly 5.9% of epilepsy patients on gabapentin versus 4.2% on placebo. Unusual eye movements are also listed among the most common side effects.
Across all clinical trials (not just controlled ones), the broader list of reported eye problems includes dry eyes, eye pain, visual field changes, and photophobia at infrequent rates. Glaucoma, iritis, and corneal problems appear in the rare category. These rare listings don’t necessarily mean gabapentin caused them, only that they were reported during the study period.
Monitoring Your Eyes on Gabapentin
Because the incidence of serious eye problems with gabapentin is low, routine eye screening specifically for this medication is not widely recommended by clinical guidelines. An annual visual field test during a standard eye exam with an optometrist or ophthalmologist is considered reasonable for people on long-term gabapentin therapy. This is especially true for anyone taking it alongside other medications known to affect eye pressure.
If you notice sudden eye pain, a rapid change in vision, redness, or halos around lights while taking gabapentin, those symptoms warrant urgent evaluation. These are hallmarks of acute angle-closure, which requires prompt treatment to prevent permanent vision loss. Gradual, mild blurriness or double vision, on the other hand, is a more common and less alarming side effect that often stabilizes as your body adjusts to the medication.